No to Sinovac | Inquirer Opinion

No to Sinovac

/ 04:01 AM April 19, 2021

As long-time Makati residents and business owners, my wife and I have always been supportive of the Binays as leader of our beloved city, from the time of Jojo Binay, and now his youngest child, the hardworking Mayor Abby.

And we were so happy when she announced that we (seniors after the frontline health workers) would be vaccinated with AstraZeneca after it got the highest vote in a preference poll they conducted last year.

Our high spirits turned to disappointment, however, when, upon showing up at the San Lorenzo Gym for our scheduled vaccination on April 13, we were told that we would be jabbed with Sinovac instead of the promised brand.

Article continues after this advertisement

We, along with a good number of San Lorenzo Village residents, decided to walk out.

FEATURED STORIES

Why would we settle for a brand that has the lowest efficacy rate among the World Health Organization-approved vaccines? And Sinovac is NOT recommended for seniors!

As dutiful taxpayers, we won’t settle for nothing less than the best vaccine, because:

Article continues after this advertisement

1) We don’t believe in the quality of Sinovac and the intention that comes with it from the Chinese government;

Article continues after this advertisement

2) We are holding Mayor Abby to her promise.

ED DAMES
San Lorenzo Village, Makati City
[email protected]

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: CoronaVac, COVID-19 vaccines, Ed Dames, Letters to the Editor, Sinovac BioTech

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.